Department of Plastic Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Department of Orthopedic Surgery, University of Texas Health Science Center, San Antonio, Texas, USA.
Int Wound J. 2024 Oct;21(10):e70072. doi: 10.1111/iwj.70072.
The objective of the study was to compare outcomes in patients with complete surgical resection versus partial resection of diabetic foot osteomyelitis (OM). A post hoc analysis of 171 patients with OM was performed using data from two randomized clinical trials. OM was confirmed with bone culture or histopathology. Surgical culture specimens were obtained from resected bone and sent for histopathology and microbiology. Residual osteomyelitis (RO) was defined as a positive resected margin on culture or histopathology. No residual osteomyelitis (NRO) was defined as no growth from bone culture and no histopathological inflammation in the biopsy of the resection margin. Data from the 12-month follow-up were used to determine clinical outcomes. During the index hospitalization, NRO patients had significantly shorter duration of antibiotic therapy (NRO 21.0, 13.0-38.0 vs. RO 37.0, 20.8-50.0, p <0.01) and more amputations than patients with RO (NRO 89.9% vs. RO 60.9%, p <0.01). During the 12-month follow-up, patients with NRO also had significantly shorter duration of antibiotic therapy (NRO 42, 21.0-66.5 vs. RO 50.5, 35.0-75.0, p = 0.02). During the 12-month follow-up, there was no difference in ulceration at the same site (NRO 3.7%, RO 4.3% p = 0.85), hospitalization (NRO 32.6%, RO 34.8%, p = 0.76), total re-infections (NRO 25.3%, RO 29.3%, p = 0.56), re-infection with osteomyelitis (NRO 13.3% vs. 13.5%, p = 0.36), amputation (NRO 8.8%, RO 5.4%, p = 0.86) and time to wound healing in days (NRO 94, 41.0-365 vs. RO 106, 42.8-365, p = 0.77). Successful treatment of osteomyelitis was achieved by 86.7% and 86.5% of patients. During the index hospitalization, patients with no residual osteomyelitis had more amputations and were treated with antibiotics for a shorter duration. During the 12-month follow-up, patients with no residual osteomyelitis had shorter durations of antibiotics. There were no differences in re-infection, amputation, re-ulceration or hospitalization. Level of evidence: 1.
本研究旨在比较糖尿病足骨髓炎(OM)患者行完全手术切除与部分切除的结局。对两项随机临床试验的 171 例 OM 患者数据进行了事后分析。通过骨培养或组织病理学证实 OM。从切除的骨中获得手术培养标本,并进行组织病理学和微生物学检查。残留骨髓炎(RO)定义为培养或组织病理学检查切除边缘阳性。无残留骨髓炎(NRO)定义为骨培养无生长且切除边缘活检无组织病理学炎症。使用 12 个月随访的数据确定临床结局。在索引住院期间,NRO 患者的抗生素治疗持续时间明显更短(NRO 21.0,13.0-38.0 比 RO 37.0,20.8-50.0,p<0.01),截肢率也高于 RO 患者(NRO 89.9%比 RO 60.9%,p<0.01)。在 12 个月的随访期间,NRO 患者的抗生素治疗持续时间也明显更短(NRO 42,21.0-66.5 比 RO 50.5,35.0-75.0,p=0.02)。在 12 个月的随访期间,同一部位溃疡(NRO 3.7%,RO 4.3%,p=0.85)、住院(NRO 32.6%,RO 34.8%,p=0.76)、总再感染(NRO 25.3%,RO 29.3%,p=0.56)、再感染合并骨髓炎(NRO 13.3%比 13.5%,p=0.36)、截肢(NRO 8.8%,RO 5.4%,p=0.86)和伤口愈合时间(NRO 94,41.0-365 比 RO 106,42.8-365,p=0.77)均无差异。86.7%和 86.5%的患者成功治疗了骨髓炎。在索引住院期间,无残留骨髓炎的患者截肢更多,抗生素治疗时间更短。在 12 个月的随访期间,无残留骨髓炎的患者抗生素治疗时间更短。再感染、截肢、再溃疡或住院无差异。证据水平:1。